P17.33.A BLOOD GROUP 0 ATTRIBUTES TO PROLONGED PFS, OS AND FIVE-YEAR SURVIVAL IN IDH-WILDTYPE GLIOBLASTOMA PATIENTS WITH MGMT PROMOTER METHYLATION
P17.33.A 血型 O 与 MGMT 启动子甲基化的 IDH 野生型胶质母细胞瘤患者的无进展生存期 (PFS)、总生存期 (OS) 和五年生存期延长相关
期刊:Biomedical Optics Express
影响因子:3.2
doi:10.1364/BOE.7.003979
Perekatova, Valeriya; Subochev, Pavel; Kleshnin, Mikhail; Turchin, Ilya; Rodriguez Nava, Guillermo; AlGain, Sulwan; McIntyre, Karen; Miranti, Eugenia; Shepard, John; Shieh, Lisa; Sampson, Mindy; Salinas, Jorge; Kloss, M; Jost, J; Troschel, F; Troschel, B; Eich, H; Thomas, C; Lemcke, L; Stummer, W; Wiewrodt, D; Wiewrodt, R